PRLD vs SMFG
Prelude Therapeutics Inc (PRLD) versus SMFG (SMFG) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
SMFG (SMFG) common stock.
Latest reported PRLD revenue for 2026-06-30 was $10.3M. Net income was -$24.3M. PRLD currently screens at market cap $346.5M.
SMFG does not have a complete income-statement cache yet.
PRLD currently screens at market cap $346.5M. SMFG currently screens at market cap $0.
Not investment advice. Open the PRLD and SMFG stock pages for the full models.
Not investment advice.